Auricchio A, Nisam S, Klein H U
Department of Cardiology, University Hospital, Magdeburg, Germany.
J Interv Card Electrophysiol. 2000 Dec;4(4):569-74. doi: 10.1023/a:1026505329169.
Despite the antiarrhythmic efficacy of amiodarone, a definitive correlation between amiodarone treatment and increased non-arrhythmic mortality in patients with heart failure and depressed ventricular function has been reported. Results from research in the field of cardiac resynchronization therapy in heart failure may provide some explanations to this observation. We discussed the hypothetical link between amiodarone and non-arrhythmic mortality, which might have a cause--effect relationship, based on cardiac electromechanical disarrangement provoked by electrophysiological properties of amiodarone.
尽管胺碘酮具有抗心律失常疗效,但已有报道称,在心力衰竭且心室功能降低的患者中,胺碘酮治疗与非心律失常性死亡率增加之间存在明确关联。心力衰竭心脏再同步治疗领域的研究结果可能为这一观察结果提供一些解释。我们基于胺碘酮的电生理特性引发的心脏机电紊乱,讨论了胺碘酮与非心律失常性死亡率之间可能存在因果关系的假设联系。